Found 4 matching trials
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
PHASE3The purpose of this study is to assess the efficacy, safety, and tolerabili...
Location
Novartis Investigative Site
Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia
PHASE4This phase IIIb study is intended to implement a consistent treatment way f...
Location
Novartis Investigative Site
Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)
PHASE3To evaluate the tolerability, safety and efficacy of 3-step titration versu...
Location
Novartis Investigative Site
16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
PHASE4To investigate the efficacy of Exelon capsule at maximal tolerated dose in ...
Location
Novartis Investigative Site